Lantern Pharma Inc (NAS:LTRN)
$ 3.81 0.05 (1.33%) Market Cap: 41.01 Mil Enterprise Value: 7.43 Mil PE Ratio: 0 PB Ratio: 1.32 GF Score: 39/100

Lantern Pharma Inc. KOL Event (Virtual) Transcript

Nov 18, 2021 / 05:00PM GMT
Release Date Price: $8.56 (-5.73%)
Nicole Leber

Hi, everybody. Thank you so much for joining us today for Lantern Pharma's World Pancreatic Cancer Day Key Opinion Leader webinar. My name is Nicole Leber with Lantern Pharma, but our speakers today include Dr. Kishor Bhatia, who is the Chief Scientific Officer at Lantern Pharma. We also have Dr. Igor Astsaturov, who is the Co-Director of the Marvin & Concetta Greenberg Pancreatic Cancer Institute at Fox Chase Cancer Center. And we also have Dr. Ira Sharp joining us today, who is a physician, pancreatic cancer survivor and patient advocate. And with that, I will turn things over to Dr. Astsaturov.

Igor Astsaturov

Thank you, Nicole. Yes, November 18, Thursday is the World Pancreatic Cancer Day. And we use this opportunity to raise awareness on every possible stage of the urgency to develop new treatment options for patients who suffer from pancreatic cancer. It's a disease that is very difficult to treat and is rising in its incidents. We still understand poorly what causes this rise in the incidence of pancreatic cancer. And this is projected to be the third

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot